PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
PVCT was delisted on the 13th of October, 2016.
6 hedge funds and large institutions have $14K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 3 → 6 (+3)
27% more capital invested
Capital invested by funds: $11K → $14K (+$3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
+$2K |
| 2 |
ACM
Academy Capital Management
Waco,
Texas
|
+$1K |
Top Sellers
PVCT Hedge Fund Activity: Q3 2018 in Review
6 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q3 2018, worth a combined $14K — up 27% from $11K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PVCT positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cutter & Co Brokerage, opening a new position worth an estimated $2K.
- 6 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q3 2018, up from 3 in Q2 2018.
- Funds reported $14K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q3 2018, up 27% quarter-over-quarter.
- 3 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q3 2018 and 0 closed out, a net change of +3 holders.
- The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) buyer in Q3 2018 was Cutter & Co Brokerage, an estimated $2K added.
Based on aggregated 13F filings for Q3 2018.